EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pulmonary Myeloid Cells in Mild Cases of COVID-19 Upregulate the Intracellular Fc Receptor TRIM21 and Transcribe Proteasome-Associated Molecules

Andrea Henriques-Pons iD, Maria Clicia S Castro iD, Vanessa S Silva, Maiana O C Costa, Helena S I L Silva, Maria Emilia M T Walter, Anna Cristina C Carvalho iD, Alba C M A Melo, Kary Ocaña, Marcelo T Dos Santos iD, Marisa F Nicolas iD, Fabrício A B Silva iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26062769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Andrea Henriques-Pons und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil. Hauptthemen laut MEDLINE: COVID-19, Ribonucleoproteins, Proteasome Endopeptidase Complex, Myeloid Cells. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: fundação oswaldo cruz, INOVA program of Fundação Oswaldo Cruz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Much remains to be understood about COVID-19, but the protective role of antibodies (Igs) is widely accepted in SARS-CoV-2 infection. Igs’ functions are mainly carried out by receptors that bind to their Fc portion (FcR), and less attention has been dedicated to the cytoplasmic members of this family. In this work, we used single-cell RNA sequencing (scRNA-seq) data to discern cell populations in bronchoalveolar lavage fluid obtained from healthy individuals and patients with mild or severe COVID-19. Then, we evaluated the transcription of neonatal FcR (FcRn, FCGRT gene) and tripartite motif-containing protein 21 (TRIM21) and its downstream signaling components. The TRIM21 pathway is vital for virus infections as it has a dual function, leading opsonized viruses to degradation by proteasomes and the activation of innate inflammatory anti-virus response. The transcriptional level of FCGRT showed no statistical differences in any cell population comparing the three groups of patients. On the other hand, TRIM21 transcription was significantly higher in myeloid cells collected from patients with mild COVID-19. When comparing mild with severe cases, there was no statistical difference in TRIM21 transcription in lung adaptive lymphoid cells and innate lymphoid cells (ILC). Yet, we analyzed the transcription of all downstream signaling molecules in myeloid and, as most cells expressed the receptor, in adaptive lymphoid cells. Moreover, ILCs from mild cases and all cell populations from severe cases were missing most downstream components of the pathway. We observed that members of the ubiquitin–proteasome system (UPS) and other components associated with TRIM21 proteasomal degradation were transcribed in mild cases. Despite the transcription of the danger sensors DDX58 and IFIH1, the transcriptional level of inflammatory IL1B and IL18 was generally very low, along with the NLRP3 danger sensor, members of the NF-κB pathway, and TNF. Therefore, our data suggest that TRIM21 may contribute to SARS-CoV-2 protection by reducing the viral load, while the inflammatory branch of the pathway would be silenced, leading to no pathogenic cytokine production.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19RibonucleoproteinsProteasome Endopeptidase ComplexMyeloid CellsReceptors, FcLungHumansSARS-CoV-2MaleFemaleMiddle AgedUp-RegulationAdultBronchoalveolar Lavage FluidAgedSignal TransductionSS-A Antigen

Stichwörter der Autor:innen

COVID-19Fc receptorsTRIM21inflammatory responsescRNA-seq

Substanzen

RibonucleoproteinsProteasome Endopeptidase ComplexReceptors, FcSS-A Antigen

Autor:innen und Institutionen

  • Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil.
  • Department of Informatics and Computer Science, State University of Rio de Janeiro, Rio de Janeiro 20550-900, Brazil.
  • Scientific Computing Program, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil.
  • Computational Modeling Department, National Laboratory for Scientific Computing, Petropolis 15651-075, Brazil.
  • Department of Computer Science, University of Brasilia, Campus Universitário Darcy Ribeiro, Brasilia 70910-900, Brazil.

ORCID-Profile: Andrea Henriques-Pons, Maria Clicia S Castro, Anna Cristina C Carvalho, Marcelo T Dos Santos, Marisa F Nicolas, Fabrício A B Silva

Förderung

  • fundação oswaldo cruz
  • INOVA program of Fundação Oswaldo Cruz

Zitieren

APA

Henriques-Pons, A., Castro, M. C. S., Silva, V. S., Costa, M. O. C., Silva, H. S. I. L., Walter, M. E. M. T., Carvalho, A. C. C., Melo, A. C. M. A., Ocaña, K., Santos, M. T. D., Nicolas, M. F., & Silva, F. A. B. (2025). Pulmonary Myeloid Cells in Mild Cases of COVID-19 Upregulate the Intracellular Fc Receptor TRIM21 and Transcribe Proteasome-Associated Molecules. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062769

Vancouver

Henriques-Pons A, Castro MCS, Silva VS, Costa MOC, Silva HSIL, Walter MEMT, et al. Pulmonary Myeloid Cells in Mild Cases of COVID-19 Upregulate the Intracellular Fc Receptor TRIM21 and Transcribe Proteasome-Associated Molecules. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062769

BibTeX
@article{HenriquesPons2025,
  author = {Henriques-Pons, Andrea and Castro, Maria Clicia S and Silva, Vanessa S and Costa, Maiana O C and Silva, Helena S I L and Walter, Maria Emilia M T and Carvalho, Anna Cristina C and Melo, Alba C M A and Ocaña, Kary and Santos, Marcelo T Dos and Nicolas, Marisa F and Silva, Fabrício A B},
  title = {Pulmonary Myeloid Cells in Mild Cases of COVID-19 Upregulate the Intracellular Fc Receptor TRIM21 and Transcribe Proteasome-Associated Molecules},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26062769}
}
Kostenlos starten →